Article
Mammalian genotoxicity assessment of methylene blue in plasma: implications for virus inactivation.
Transfusion - 1 May 1995
Wagner S J, Cifone M A, Murli H, Dodd R Y, Myhr B
Abstract excerpt
BACKGROUND: The risk of adverse consequences of virus-inactivation procedures for plasma and cellular blood components must be less than the risk of transfusion-associated viral disease. Previous studies demonstrated that methylene blue, which is currently used in Europe for virus inactivation in fresh-frozen plasma, can elicit mutations in bacterial test systems. This study investigates the potential for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
